Skip to main content

Table 3 Acute toxicity

From: CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

Toxicity Grade 1 No. (%) Grade 2 No. (%) Grade 3 No. (%) Grade 4 No. (%)
Hematological     
  Leukocytopenia 9 (12.7) 6 (8.5) 4 (5.6) 2 (2.8)
  Thrombocytopenia 1 (1.4) 0 0 0
Non-hematological     
  Diarrhea 21 (29.6) 14 (19.7) 16 (22.5) 0
  Cystitis 12 (16.9) 9 (12.7) 3 (4.2) 0
  Dermatitis 8 (8.5) 13 (18.3) 7 (9.9) 0
  Vomiting 4 (5.6) 3 (4.2) 0 0
  Hand-foot syndrome 4 (5.6) 2 (2.8) 0 0